Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2001
06/07/2001WO2001040277A2 Carbohydrate-aminated glycoproteins
06/07/2001WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
06/07/2001WO2001040275A2 Peptides that stabilize protein antigens and enhance presentation to cd8+ t cells
06/07/2001WO2001040274A2 Inhibition of hrsv membrane fusion
06/07/2001WO2001040273A2 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders
06/07/2001WO2001040271A2 Cancer associated antigens and uses therefor
06/07/2001WO2001040270A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies
06/07/2001WO2001040269A2 Compositions and methods for therapy and diagnosis of breast cancer
06/07/2001WO2001040268A2 Beryllofluoride analogues of acyl phosphate polypeptides
06/07/2001WO2001040267A2 Proteoglycans and pharmaceutical compositions comprising them
06/07/2001WO2001040266A2 Insect poison allergens with reduced ige reactivity and method for producing the same
06/07/2001WO2001040264A2 Peptide antigens
06/07/2001WO2001040261A1 Method of diagnosing neurodegenerative disease
06/07/2001WO2001040259A2 Monkey orexin 1 receptor
06/07/2001WO2001040258A2 Educational kit and method using tumor necrosis factor-stimulated gene and protein
06/07/2001WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them
06/07/2001WO2001040252A1 Monkey calcium sensing receptor
06/07/2001WO2001040251A1 Transforming growth factor alpha hiii
06/07/2001WO2001040250A1 Cotton transcription factors and their uses
06/07/2001WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
06/07/2001WO2001040248A1 Cryptosporidium sporozoite antigens
06/07/2001WO2001040247A1 Interleukin-1 homologue, mat il-1h4
06/07/2001WO2001040142A2 P21 derived peptides capable of inhibiting cdk/cyclin complexes
06/07/2001WO2001039802A1 Chimeric flavivirus vaccines
06/07/2001WO2001039801A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
06/07/2001WO2001039799A2 Passive desensitization
06/07/2001WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
06/07/2001WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
06/07/2001WO2001039796A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
06/07/2001WO2001039793A2 Pharmaceutical compositions containing sema7a polypeptides
06/07/2001WO2001039788A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2
06/07/2001WO2001039786A2 New uses of suppressive macrophage activation factors
06/07/2001WO2001039722A2 B7-h1, a novel immunoregulatory molecule
06/07/2001WO2001039600A1 Use of hsp27 as an anti-inflammatory agent
06/07/2001WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences
06/07/2001WO2001027137A3 Rattus norvegicus (edg3)
06/07/2001WO2001025270A3 PLANT APOPTOSIS INDUCING FACTORS (AIFs)
06/07/2001WO2001016158A3 Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor
06/07/2001WO2001013946A3 Method for isolating and purifying grass pollen allergens
06/07/2001WO2001012798A3 Male sterile plants
06/07/2001WO2001012213A3 Ttp-related zinc finger domains and methods of use
06/07/2001WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy
06/07/2001WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby
06/07/2001WO2001007612A3 Receptors and associated proteins
06/07/2001WO2001001775A8 Preserving a hemoglobin blood substitute with a transparent overwrap
06/07/2001WO2000078960A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/07/2001WO2000032752A9 Psca: prostate stem cell antigen and uses thereof
06/07/2001WO1999063071A3 Method for triggering apoptosis in cells
06/07/2001WO1999052548A9 Conjugate vaccines for the prevention of dental caries
06/07/2001DE19957916A1 Neue Proteinkonjugate und Verfahren zu deren Herstellung New protein conjugates and methods for their preparation
06/07/2001DE19957904A1 Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung Insect venom allergens with reduced IgE-reactivity, and methods for their preparation
06/07/2001DE19957043A1 Neue Defensine New defensins
06/07/2001DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use
06/07/2001CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2496312A1 Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same
06/07/2001CA2494705A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2492070A1 Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same
06/07/2001CA2492049A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2491610A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2491433A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2491258A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2490909A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2490853A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
06/07/2001CA2397731A1 Immunogen antivenom and vaccine against the venom of the black widow sp ider
06/07/2001CA2394996A1 Transcription factors containing two potential dna binding motifs
06/07/2001CA2394016A1 Novel endoplasmic localization proteins,therapeutic agents for glycoprotein aberration disorders containing same,dna encoding the proteins,and therapeutic agents in gene therapy for glycoprotein aberration disorders
06/07/2001CA2393527A1 Educational kit and method using tumor necrosis factor-stimulated gene and protein
06/07/2001CA2393369A1 Human cytokine receptor
06/07/2001CA2393325A1 Infectious clones
06/07/2001CA2393004A1 Method of diagnosing neurodegenerative disease
06/07/2001CA2392991A1 Semaphorin receptor
06/07/2001CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
06/07/2001CA2392958A1 Methods and compositions for regulating lymphocyte activity
06/07/2001CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
06/07/2001CA2392946A1 Novel abcb9 transporter and uses thereof
06/07/2001CA2392939A1 Naive screening method
06/07/2001CA2392933A1 Cryptosporidium sporozoite antigens
06/07/2001CA2392906A1 Pseudomonas aeruginosa antigens
06/07/2001CA2392895A1 Streptococcus pneumoniae antigens
06/07/2001CA2392853A1 Hbv sequences
06/07/2001CA2392805A1 Dna fragment having promoter activity
06/07/2001CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies
06/07/2001CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
06/07/2001CA2392510A1 Compositions and methods for therapy and diagnosis of breast cancer
06/07/2001CA2392508A1 Method of judging flocculating properties of bottom brewer's yeast
06/07/2001CA2392477A1 B7-h1, a novel immunoregulatory molecule
06/07/2001CA2392110A1 Proteins and nucleic acids encoding the same
06/07/2001CA2391455A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2001CA2391404A1 Udp-glucose:aglycon-glucosyltransferase
06/07/2001CA2390839A1 Transforming growth factor alpha hiii
06/07/2001CA2390786A1 Compositions and methods for the treatment of immune related diseases
06/07/2001CA2390415A1 New uses of suppressive macrophage activation factors
06/07/2001CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/07/2001CA2389262A1 Modified il-12 subunits and nucleic acids encoding them
06/07/2001CA2388678A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
06/07/2001CA2388559A1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
06/07/2001CA2388538A1 Bacillus thuringiensis toxin active against formicidae (ant)
06/07/2001CA2388205A1 Schizophrenia associated gene, proteins and biallelic markers
06/07/2001CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use